123 Smart Healthcare Co-Hosts the First STI Digital Health Annual Conference and Files IPO Prospectus

The “1st STI Digital Healthcare Annual Conference,” hosted by the National Science and Technology Information Resource Comprehensive Utilization and Public Service Center (hereinafter referred to as “STI”) and co-organized by the Scientific and Technical Literature Press, Fudan University’s Sixth Industry Research Institute, and 123 Smart Healthcare Group, will be officially held in Beijing on March 24.

This conference is dedicated to implementing the “Outline of the Healthy China 2030 Plan” and promoting digital healthcare innovation services and research led by next-generation information technologies such as big data and artificial intelligence. Centered on the theme “Digital-Driven Evolution of Medical Value Delivery and Research Paradigms,” it invites representatives from relevant national ministries, scientific research institutions, universities, and the digital health industry to discuss the evolution of digital-driven medical research paradigms in the context of digital healthcare trends.

It is understood that during the conference, invited guests will engage in in-depth discussions on the medical value delivered by digital healthcare across multiple dimensions, including clinical medical research, medical value, disease-specific management, application of medical big data, and the integration of digital healthcare with scientific research. The event aims to establish an authoritative academic platform for exchange and collaboration to foster the convergence of medicine and technology, thereby facilitating the creation of multi-channel digital application scenarios.

As a co-organizer of the “1st STI Digital Health Annual Conference,” 123 Smart Healthcare Group is a digital health enterprise that provides integrated, whole-course disease management services in the field of specialized disciplines and specific diseases. Since its establishment, the company has upheld the philosophy of “service as research,” driving patient-centered, continuous, and proactive management through evidence-based medicine and real-world data studies, thereby enhancing long-term treatment outcomes and clinical research efficiency in the field of major diseases.

To accelerate the integration of digital healthcare and clinical research, 123 Smart Healthcare Group has taken the lead in establishing China’s first research-oriented internet hospital. It assists departments and physicians in digitizing and migrating clinical medical technologies and practical experience to online platforms, while jointly developing digital therapeutics for clinical treatment or adjunctive therapy. This initiative aims to improve patient outcomes, facilitate the translation of clinical achievements, and promote the convergence of digital healthcare and medical scientific research.

Riding the fast lane of digital development, Yiersan Smart Healthcare Group is dedicated to safeguarding people’s lives and health. Leveraging information technologies such as big data, artificial intelligence, and the Internet of Things (IoT), the group focuses on innovative services and scientific research in digital healthcare within the field of major diseases.

To date, we have developed the Disease-Specific Integrated Care Management (DSICM) system, the IoT-based Proactive Health Management System, an integrated research and analysis platform, and an evidence-based medicine knowledge base and knowledge graph that includes resources from the Youlan Medical Knowledge Center. Furthermore, the company has built an IoT platform integrating data sensing, risk identification, and proactive intervention for risk factors, along with an intelligent disease management engine and a smart hardware service ecosystem. These initiatives enable the creation of digital therapeutics for specific diseases and provide intelligent clinical decision support, thereby enhancing physicians’ workflow efficiency and delivering more timely, proactive interventions and dynamic management plans for patients.

In the digital healthcare ecosystem, digital whole-course disease management plays a pivotal role. On digital management platforms, patients can receive long-term professional care, thereby reducing the risk of disease progression. Meanwhile, real-world data generated through patient engagement serves as crucial evidence for clinicians conducting real-world studies, facilitating clinical research.

Nowadays, digital healthcare is becoming increasingly integrated with clinical research, and problem-oriented clinical research has become the choice of more and more researchers. The "First STI Digital Healthcare Annual Conference" will undoubtedly provide more clinical medical workers with opportunities to understand digital healthcare and promote the development of the digital healthcare industry.